Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:32587965  

Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate.

Christiane Iserman | Christine Roden | Mark Boerneke | Rachel Sealfon | Grace McLaughlin | Irwin Jungreis | Chris Park | Avinash Boppana | Ethan Fritch | Yixuan J Hou | Chandra Theesfeld | Olga G Troyanskaya | Ralph S Baric | Timothy P Sheahan | Kevin Weeks | Amy S Gladfelter
bioRxiv : the preprint server for biology | 2020

A mechanistic understanding of the SARS-CoV-2 viral replication cycle is essential to develop new therapies for the COVID-19 global health crisis. In this study, we show that the SARS-CoV-2 nucleocapsid protein (N-protein) undergoes liquid-liquid phase separation (LLPS) with the viral genome, and propose a model of viral packaging through LLPS. N-protein condenses with specific RNA sequences in the first 1000 nts (5'-End) under physiological conditions and is enhanced at human upper airway temperatures. N-protein condensates exclude non-packaged RNA sequences. We comprehensively map sites bound by N-protein in the 5'-End and find preferences for single-stranded RNA flanked by stable structured elements. Liquid-like N-protein condensates form in mammalian cells in a concentration-dependent manner and can be altered by small molecules. Condensation of N-protein is sequence and structure specific, sensitive to human body temperature, and manipulatable with small molecules thus presenting screenable processes for identifying antiviral compounds effective against SARS-CoV-2.

Pubmed ID: 32587965

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: F32 GM128330
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009156
  • Agency: NHLBI NIH HHS, United States
    Id: U54 HL117798
  • Agency: NIGMS NIH HHS, United States
    Id: R35 GM122532
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM071966
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM081506
  • Agency: NHGRI NIH HHS, United States
    Id: R01 HG005998
  • Agency: NIGMS NIH HHS, United States
    Id: F32 GM136164
  • Agency: NIAID NIH HHS, United States
    Id: HHSN272201000054C

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


QIAGEN (tool)

RRID:SCR_008539

A commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

View all literature mentions

Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

Sigma-Aldrich (tool)

RRID:SCR_008988

American chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.

View all literature mentions

New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

Vero C1008 (tool)

RRID:CVCL_0574

Cell line Vero C1008 is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions